170.987 Reducing Risk of Federal Investigation or Prosecution for Prescribing
That MSSNY support legislative, regulatory, and other advocacy efforts that (1) advance the adoption of a conjunctive standard in the context of “legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice” under the federal Controlled Substances Act and implementing regulations and (2) address relevant federal regulations to clarify that “legitimate medical purpose” means “for the purpose of preventing, treating, or managing a patient’s health-related condition” and MSSNY forward this resolution to the AMA for legislative or regulatory action at the federal level. (HOD 2025-64)
